Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Dr Arun recently had TULSA

<< Previous

Bullboard Posts

Next >>

Comment by Charlie263on Jul 02, 2021 11:39am

224 Views

Post# 33482044

RE:RE:Dr Arun recently had TULSA

The case for TULSA is promising. It's target patient base in just US is 500k approx. Assuming it just tap in 25% of market i.e. 125,000 patients per year by 2025...that will bring this company to approx. USD 1 Billion plus annual revenue just in US. from TULSA. It's a matter of time, patience and vision...if all goes well ...PROF is going to fly high...

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing